Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

CareDx

Adaptive Biotechnologies

Veracyte

Ionis Pharma

Nurix Therapeutics, Inc

Intellia Therapeutics

10X Genomics

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

ARK Industrial Innovation ETF

DraftKings

Palantir Technologies

Tencent Holdings Limited

Teladoc

Zoom Video

ARK Invest buys this week have some stocks taking off as the private investment firm picks up shares on the stock market dip. The post ARK Invest Buys: What Stocks Is Cathie Wood Buying on the Dip This Week?

ARK Invest Buys: What Stocks Is Cathie Wood Buying on the Dip This Week?

AbbVie

There's a pretty good chance the answer is "yes."

Warren Buffett and Cathie Wood Just Bought This Juicy Dividend Stock. Should You?

ARK Fintech Innovation ETF

ARK Innovation ETF

ARK Web x.0 ETF

ARK Invest has been the talk of Wall Street over the last couple of years, outperforming the market and solidifying its place among the big players in the investments world.

Cathie Wood's ARK Invest Buys and Sells 3/1

The ARK Genomic Revolution Multi-Sector ETF has delivered the best return of all ARK funds over the last year, rising 173%. However, it's also one of the riskier ARK funds, going by both quantifiable measures and "soft" factors.

ARK Genomic Revolution Multi-Sector ETF: Proceed With Caution

The volatile tech sell-off that has roiled markets so far this week helped spur record withdrawals from Cathie Wood's Ark Invest funds, according to data compiled by Bloomberg. The ARK Innovation ETF, which invests in disruptive technology like electric vehicles and autonomous driving, saw outflows of $465 million on Monday. The ARK Genomic Revolution ETF and the ARK Next Generation Internet ETF were also hit with sizable investor withdrawals: $202 million and $119 million respectively.

Cathie Wood's flagship Ark Innovation fund suffers worst outflows on record amid tech decline

Ark Invest funds like the ARKK ETF are falling today thanks to big bets on Tesla and Bitcoin. Here's why the big picture is still bright.

Ark Invest Funds: Why ARKG, ARKF, ARKQ and the ARKK ETF Are Stumbling

Cathie Wood's Ark Invests Buys and Sells 2/22

Novartis

Pacific Biosciences of California

Regeneron Pharmaceuticals

Roche Holding AG

Takeda Pharmaceutical

Thermo Fisher Scientific

Vertex Pharmaceuticals

Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality.

ARKG: Precautionary Measures, But Transformational Objectives Remain Intact

Energy Select Sector SPDR Fund

The February rally has been historic, and investors seem optimistic amid signs of economic recovery, the vaccine rollout, and more positive news. Nonetheless, there are fears of a bubble.

ARK Innovation Among The Top ETFs This Week As The Market Keeps Rolling

Get the latest on the red-hot active ETF manager's moves.

5 Cathie Wood Stocks That Were Big ARK Invest Buys Last Week

When it comes to investing in companies with exposure to the rapidly evolving early cancer detection/screening market, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) stands above the rest. Part of the early cancer screening equation is liquid biopsies, a niche some ARKG components already feature exposure to.

Liquid Biopsies? Just Another Day in the Life for ‘ARKG'

Look past the retail trading hype surrounding Reddit forums and investors will see ETFs from ARK Invest producing blockbuster gains. Five of its active management funds have been an overarching theme amongst outperforming funds in recent days.

Today's OverARKing Theme? 5 Active ETFs from Ark Invest

Amplify Seymour Cannabis ETF

AdvisorShares Pure Cannabis ETF 

The best healthcare ETFs for Q2 2021 are ARKG, CNBS, and YOLO.

Best Healthcare ETFs for Q2 2021

Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure. Enter the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG).

Cancer Screening? There's an ARK ETF for That

Active ETFs pulled in a record of more than $55 billion capital last year and $17.5 billion so far this year, bringing their AUM to $200 billion.

Ark Invest ETFs Power Active Investing Growth

ARKG has outperformed the high-flying Genomics and Biotech ETF competition over the long and short term. Management has proven that the frequent and large scale changes in the portfolio are a huge benefit to the fund.

ARKG: Dynamic And Fluid Enough To Continue To Provide Strong Returns

iShares MSCI EAFE Value ETF

iShares Core MSCI Emerging Markets ETF

Vanguard Total Stock Market ETF

Financial Select Sector SPDR Fund

A few ETFs have garnered solid investors' interest to start a New Year and will continue to be their darlings in the month of love.

6 Hot ETFs That Could be Investors' Darling in February

iShares Genomics Immunology and Healthcare ETF

SPDR S&P Biotech ETF

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Best Biotech ETFs for Q2 2021

Ground zero for disruptive growth in the healthcare sector is genomics through the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG holds equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the fund's genomics theme.

Unlock the Long-Term Genomics Runway with ‘ARKG'

Next generation sequencing (NGS) is here, and its long-term evolution could spark significant upside for exchange traded funds like the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Long DNA is a new frontier in the genomics space, but it's applications are critical given the role genetics plays in treating an array of diseases.

Long Read Sequencing Is Here. The ARKG ETDF Is Ready

Here's how you can share in this newly recognized investing pro's success.

Like Star Investor Cathie Wood? 6 Ways to Profit From Her Picks

The 3D Printing ETF

Investors can tap into exchange traded fund strategies that capture these to capture disruptive innovations and enhance portfolios. In the recent webcast, Big Ideas 2021: Technological Breakthroughs Investors Shouldn't Miss, Catherine Wood, Founder, CEO, CIO, ARK Invest, highlighted breakthrough technologies that will change the global economy and open growth opportunities for investors.

Targeted ETF Strategies to Capture Technological Breakthroughs

Investors looking for disruptive growth in the healthcare sector need not look beyond the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG's stellar track record is rooted in ARK Investment Management's ability to put together a portfolio that is reflective of the myriad growth avenues in the genomics space today.

An ‘Omics Revolution: What's Next for High-Flying ‘ARKG'

Genomics is one of the premier disruptive technologies. While several exchange traded funds provide access to this fast-growing industry, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is arguably the best when it comes to keeping pace with the rapidly changing world of genomics advances.

ARKG: Access the Latest and Greatest Genomics Innovation

We highlight the best performing ETFs managed by Cathie Wood

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)